Show simple item record

dc.contributor.authorJ Gordon Millichap
dc.contributor.otherNorthwestern University Feinberg School of Medicine
dc.date.accessioned2015-12-17T05:30:13Z
dc.date.available2025-10-02T04:04:55Z
dc.date.issued01-10-2011
dc.identifier.issn-
dc.identifier.urihttps://www.pediatricneurologybriefs.com/articles/684
dc.description.abstractResearchers at University of Pennsylvania School of Medicine, Duke University, Brown, Michigan, and University of Massachusetts, Worcester, as members of the Pediatric-OCD Treatment Study II (POTS II) Randomized Controlled Trial, examined effects of augmenting serotonin reuptake inhibitor (SRI) treatment with short-term cognitive behavior therapy (CBT) in 124 pediatric outpatients, 7 to 17 years of age, with a primary diagnosis of OCD.
dc.format-
dc.language.isoEN
dc.publisherPediatric Neurology Briefs Publishers
dc.relation.uri['https://www.journals.elsevier.com/neurobiology-of-disease/', 'https://www.journals.elsevier.com/neurobiology-of-disease', 'https://www.elsevier.com/authors/open-access/choice#waivers', 'https://www.elsevier.com/journals/neurobiology-of-disease/0969-9961/guide-for-authors']
dc.rights['CC BY', 'CC BY-NC-ND', 'CC BY-NC']
dc.subject['neuroscience', 'neural systems', 'neurological diseases', 'psychiatric disorders', 'neurogenetics', 'neurobiology', 'Neurosciences. Biological psychiatry. Neuropsychiatry', 'RC321-571']
dc.subject.lccPediatrics
dc.titleObsessive-Compulsive Disorder Cognitive Behavior Therapy
dc.typeArticle
dc.description.keywordsserotonin reuptake inhibitor
dc.description.keywordscognitive behavior therapy
dc.description.keywordsmedication plus instruction
dc.description.pages79-80
dc.description.doi10.15844/pedneurbriefs-25-10-10
dc.title.journalPediatric Neurology Briefs
dc.identifier.e-issn2166-6482
dc.identifier.oaioai:doaj.org/journal:9751ca34bbd040f6b4851f955f550055
dc.journal.infoVolume 25, Issue 10


This item appears in the following Collection(s)

Show simple item record